GlassScriptPhysician profile
Caleb Weber Fligor
NPI 1184243925
$1,339.38
in general payments reported to CMS, 2019-2025
14 companies · $945 in 2025
The $945 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.71 · 2023: $129 · 2024: $187 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172 · Consulting Fee: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,171.67 |
| Consulting Fee | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $153.09 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $149.30 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Organogenesis INC. | $139.71 | 2025 | Puraply Wound Matrix |
| Revance Therapeutics, INC. | $138.78 | 2025 | Daxi |
| Urgo Medical North America, LLC | $129.31 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Abbvie INC. | $126.83 | 2025 | |
| Avita Medical Americas, LLC | $117.69 | 2025 | Permeaderm, Cohealyx, Recell |
| Endo USA, INC. | $90.05 | 2025 | Xiaflex |
| Medtronic, INC. | $90.00 | 2024-2025 | Eea |
| Silk Road Medical, INC. | $77.71 | 2021 | |
| Tempus Ai, INC | $63.08 | 2024 | |
| Heron Therapeutics, INC. | $25.02 | 2024 | Zynrelef |
| Medical Device Business Services, INC. | $23.00 | 2024 | |
| Amgen INC. | $15.81 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Fligor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.